List of Excipients in API sodium phenylbutyrate/taurursodiol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sodium phenylbutyrate/taurursodiol
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | ACACIA | 2029-09-29 |
Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | DEXTRATES | 2029-09-29 |
Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | MALTODEXTRIN | 2029-09-29 |
Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | MEDIUM-CHAIN TRIGLYCERIDES | 2029-09-29 |
Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | SILICON DIOXIDE | 2029-09-29 |
Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS | 2029-09-29 |
Amylyx Pharmaceuticals Inc | RELYVRIO | sodium phenylbutyrate/taurursodiol | 73063-035 | SODIUM STEARYL FUMARATE | 2029-09-29 |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sodium phenylbutyrate/taurursodiol
Excipient focus: ACACIA
sodium phenylbutyrate/taurursodiol drug variants containing ACACIA
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing ACACIA
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: DEXTRATES
sodium phenylbutyrate/taurursodiol drug variants containing DEXTRATES
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing DEXTRATES
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MALTODEXTRIN
sodium phenylbutyrate/taurursodiol drug variants containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing MALTODEXTRIN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
sodium phenylbutyrate/taurursodiol drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sodium phenylbutyrate/taurursodiol drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
sodium phenylbutyrate/taurursodiol drug variants containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SODIUM PHOSPHATE, DIBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
sodium phenylbutyrate/taurursodiol drug variants containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SODIUM STEARYL FUMARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
sodium phenylbutyrate/taurursodiol drug variants containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SORBITOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
sodium phenylbutyrate/taurursodiol drug variants containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
Amylyx Pharmaceuticals Inc | sodium phenylbutyrate/taurursodiol | 73063-035 |
>Company | >Ingredient | >NDC |
sodium phenylbutyrate/taurursodiol drug variants not containing SUCRALOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.